UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

Leukemia, 2014-01, Vol.28 (1), p.78-87

2014

Volltextzugriff (PDF)

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Leukemia, 2013-06, Vol.27 (6), p.1301-1309

2013

Volltextzugriff (PDF)

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors

Leukemia, 2012-02, Vol.26 (2), p.244-254

2012

Volltextzugriff (PDF)

The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)

Haematologica (Roma), 2016-06, Vol.101 (6), p.688-697

2016

Volltextzugriff (PDF)

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

Leukemia, 2015-01, Vol.29 (1), p.188-195

2015

Volltextzugriff (PDF)

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Leukemia, 2010-10, Vol.24 (10), p.1799-1804

2010

Volltextzugriff (PDF)

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

Leukemia, 2011-11, Vol.25 (11), p.1739-1750

2011

Volltextzugriff (PDF)

CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors

Leukemia, 2012-07, Vol.26 (7), p.1547-1554

2012

Volltextzugriff (PDF)

Fludarabine i.v. BU conditioning regimen: myeloablative, reduced intensity or both?

Bone marrow transplantation (Basingstoke), 2008-06, Vol.41 (11), p.935-940

2008

Volltextzugriff (PDF)

Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

British journal of haematology, 2001-01, Vol.112 (1), p.195-200

2001

Volltextzugriff (PDF)

Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2006-06, Vol.37 (12), p.1099-1102

2006

Volltextzugriff (PDF)

Comparable kinetics of myeloablation between fludarabine full-dose busulfan and fludarabine melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (7), p.477-482

2006

Volltextzugriff (PDF)

The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up

American journal of hematology, 2010-06, Vol.85 (6), p.403-408

2010

Volltextzugriff (PDF)

Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A

Blood, 2004-06, Vol.103 (11), p.4102-4110

2004

Volltextzugriff (PDF)

Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

Blood, 2003-12, Vol.102 (12), p.3865-3870

2003

Volltextzugriff (PDF)

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

Blood, 2003-10, Vol.102 (8), p.3025-3027

2003

Volltextzugriff (PDF)

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Blood, 2002-09, Vol.100 (5), p.1570-1574

2002

Volltextzugriff (PDF)

EVI1 induces myelodysplastic syndrome in mice

The Journal of clinical investigation, 2004-09, Vol.114 (5), p.713-719

2004

Volltextzugriff (PDF)

Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

Seminars in hematology, 2000, Vol.37 (1), p.15-29

2000

Volltextzugriff (PDF)

DNA hypo‐methylating agents and sickle cell disease

British journal of haematology, 2004-09, Vol.126 (5), p.629-636

2004

Volltextzugriff (PDF)

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Blood, 2001-12, Vol.98 (13), p.3513-3519

2001

Volltextzugriff (PDF)

Clinical studies with fetal hemoglobin—enhancing agents in sickle cell disease

Seminars in hematology, 2004-10, Vol.41 (4), p.11-16

2004

Volltextzugriff (PDF)

HLA‐DR4 predicts haematological response to cyclosporine in T‐large granular lymphocyte lymphoproliferative disorders

British journal of haematology, 2003-11, Vol.123 (3), p.449-453

2003

Volltextzugriff (PDF)

Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process

Leukemia research, 2001-12, Vol.25 (12), p.1075-1083

2001

Volltextzugriff (PDF)

Acute graft-versus-host disease and steroid treatment impair CD11c + and CD123 + dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation

Biology of blood and marrow transplantation, 2004-02, Vol.10 (2), p.106-115

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(23)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Hematologic And Hematopoietic Diseases
(14)
Adult
(13)
Middle Aged
(13)
Oncology
(11)
Female
(10)
Male
(10)
Internal Medicine
(8)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(8)
Medicine
(8)
Medicine & Public Health
(8)
Medicine/public Health
(8)
Stem Cells
(8)
Aged
(7)
Cancer Research
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors

The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors

Fludarabine i.v. BU conditioning regimen: myeloablative, reduced intensity or both?

Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma

Comparable kinetics of myeloablation between fludarabine full-dose busulfan and fludarabine melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation

The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up

Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A

Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

EVI1 induces myelodysplastic syndrome in mice

Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

DNA hypo‐methylating agents and sickle cell disease

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Clinical studies with fetal hemoglobin—enhancing agents in sickle cell disease

HLA‐DR4 predicts haematological response to cyclosporine in T‐large granular lymphocyte lymphoproliferative disorders

Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process

Acute graft-versus-host disease and steroid treatment impair CD11c + and CD123 + dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation

Aktive Filter

Suchergebnisse filtern